Sep 9, 2010
(CIDRAP News) In a move designed to draw attention to languishing food safety legislation in the US Senate, three national consumer groups today reported that 85 food recalls have been issued in the 13 months since similar legislation passed in the House.
(CIDRAP News) – The necessity for good communication among the many parts of the healthcare system was a major theme today in a Centers for Disease Control and Prevention (CDC) teleconference on planning for public health emergencies.
Editor's note: This story was revised Sep 1 to reflect a recent change in the Infectious Diseases Society of America's position on mandatory flu vaccination for healthcare workers.
(CIDRAP News) A West Nile virus (WNV) seroprevalence study of Italian organ donors revealed that 1.2% of 1,248 serum samples were positive and that some of the donors who had been exposed to the virus were from regions where infection wasn't thought to be a risk.
(CIDRAP News) Researchers studying facial personal protective equipment (PPE) data at three Vancouver hospitals found that use of surgical masks and N-95 respirators during the 2009 H1N1 pandemic was seven times greater than earlier supply estimates and tested the plans hospitals had in place.
(CIDRAP News) The recently reported factor that can make gram-negative bacteria resistant to nearly all antibiotics is a serious concern but does not necessarily top the list of resistance worries for healthcare in the United States, say two antimicrobial resistance experts who discussed the threat this week.
(CIDRAP News) In light of vaccine production problems that delayed the delivery of the pandemic H1N1 vaccine, a report by President Barack Obama's science advisers released today said targeted investments in five specific areas could trim the time needed to quickly produce enough to protect the nation by weeks or months.
(CIDRAP News) Federal health officials, in releasing today a blueprint for overhauling the nation's civilian biodefense program, called for increased government partnerships with the private sector and a number of innovative steps to boost the development of medical countermeasures (MCMs) that have little or no commercial market.
